Dr Tjalkens draws upon history to discuss how viral pandemics such as COVID-19 offer clues into neurodegenerative disorders.
Lab poster presentations awarded at CSU’s annual event
The Olympus Discovery Summit features Tjalkens lab research on April 28, 2021 @ 11am EDT.
Novel compound reduces viral entry and inflammation in hamsters exposed to SARS-CoV-2 (bioRxiv, 2021).
NF-kB signaling in astrocytes following exposure to Mn and MPTP (Toxicol Sci., 2020).
Juvenile exposure to Mn heightens innate immune inflammation during influenza infection (PLoS One, 2021).
Can infection with SARS-CoV2 be a risk factor for developing neurodegenerative disease?